34248190|t|Effect of combinations of dexamethasone-ondansetron and dexamethasone-ondansetron-aprepitant versus aprepitant alone for early postoperative nausea and vomiting after day care gynaecological laparoscopy: A randomised clinical trial.
34248190|a|BACKGROUND AND AIMS: This study was designed to compare the effectiveness of the combination of dexamethasone-ondansetron with oral aprepitant alone and triple combination therapy with all three agents (dexamethasone-ondansetron and oral aprepitant) in the prevention of postoperative nausea and vomiting (PONV) in day care gynaecologic laparoscopy. METHODS: This was a randomised clinical trial conducted at a university teaching hospital. A total of 105 female patients were randomised into the aprepitant (A), dexamethasone-ondansetron (DO) and aprepitant-dexamethasone-ondansetron (ADO) groups. The patients in the A group received only 80 mg oral aprepitant 1 h before surgery. The patients in the DO group, received dexamethasone 8 mg at induction with ondansetron 4 mg before extubation. Patients in the ADO group received 80 mg oral aprepitant 1 h before surgery, dexamethasone 8 mg at induction and ondansetron 4 mg before extubation. Incidence of nausea and vomiting was compared between groups using the Chi-square test/Fisher's test. Bellville score for severity of PONV was analysed using the Kruskall-Wallis test. P value < 0.05 was regarded as significant. RESULTS: The incidence of PONV did not show a statistically significant difference between the three groups, with a P value of 0.13 (12.5%, 30.3% and 32.3% in groups ADO, DO and A, respectively). The severity of PONV measured using Bellville score was also not significantly different among the groups [median values (IQR) of 0 (0-0), 0 (0-1), and 0 (0-1)]. CONCLUSION: The combination of aprepitant, dexamethasone and ondansetron failed to demonstrate a statistically significant superiority over the other two antiemetic regimens.
34248190	26	39	dexamethasone	Chemical	MESH:D003907
34248190	40	51	ondansetron	Chemical	MESH:D017294
34248190	56	69	dexamethasone	Chemical	MESH:D003907
34248190	70	81	ondansetron	Chemical	MESH:D017294
34248190	82	92	aprepitant	Chemical	MESH:D000077608
34248190	100	110	aprepitant	Chemical	MESH:D000077608
34248190	127	160	postoperative nausea and vomiting	Disease	MESH:D020250
34248190	329	342	dexamethasone	Chemical	MESH:D003907
34248190	343	354	ondansetron	Chemical	MESH:D017294
34248190	365	375	aprepitant	Chemical	MESH:D000077608
34248190	436	449	dexamethasone	Chemical	MESH:D003907
34248190	450	461	ondansetron	Chemical	MESH:D017294
34248190	471	481	aprepitant	Chemical	MESH:D000077608
34248190	504	537	postoperative nausea and vomiting	Disease	MESH:D020250
34248190	539	543	PONV	Disease	MESH:D020250
34248190	696	704	patients	Species	9606
34248190	730	740	aprepitant	Chemical	MESH:D000077608
34248190	746	759	dexamethasone	Chemical	MESH:D003907
34248190	760	771	ondansetron	Chemical	MESH:D017294
34248190	773	775	DO	Chemical	-
34248190	781	791	aprepitant	Chemical	MESH:D000077608
34248190	792	805	dexamethasone	Chemical	MESH:D003907
34248190	806	817	ondansetron	Chemical	MESH:D017294
34248190	819	822	ADO	Chemical	-
34248190	836	844	patients	Species	9606
34248190	885	895	aprepitant	Chemical	MESH:D000077608
34248190	920	928	patients	Species	9606
34248190	936	938	DO	Chemical	-
34248190	955	968	dexamethasone	Chemical	MESH:D003907
34248190	992	1003	ondansetron	Chemical	MESH:D017294
34248190	1028	1036	Patients	Species	9606
34248190	1044	1047	ADO	Chemical	-
34248190	1074	1084	aprepitant	Chemical	MESH:D000077608
34248190	1105	1118	dexamethasone	Chemical	MESH:D003907
34248190	1141	1152	ondansetron	Chemical	MESH:D017294
34248190	1190	1196	nausea	Disease	MESH:D009325
34248190	1201	1209	vomiting	Disease	MESH:D014839
34248190	1311	1315	PONV	Disease	MESH:D020250
34248190	1431	1435	PONV	Disease	MESH:D020250
34248190	1571	1574	ADO	Chemical	-
34248190	1576	1578	DO	Chemical	-
34248190	1617	1621	PONV	Disease	MESH:D020250
34248190	1794	1804	aprepitant	Chemical	MESH:D000077608
34248190	1806	1819	dexamethasone	Chemical	MESH:D003907
34248190	1824	1835	ondansetron	Chemical	MESH:D017294
34248190	Negative_Correlation	MESH:D000077608	MESH:D009325
34248190	Cotreatment	MESH:D003907	MESH:D017294
34248190	Negative_Correlation	MESH:D003907	MESH:D020250
34248190	Cotreatment	MESH:D000077608	MESH:D003907
34248190	Negative_Correlation	MESH:D000077608	MESH:D020250
34248190	Cotreatment	MESH:D000077608	MESH:D017294
34248190	Negative_Correlation	MESH:D017294	MESH:D020250

